Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Animal Models

AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model

Leukemia volume 24, pages 1018–1024 (2010)Cite this article

Subjects

Abstract

Activation-induced cytidine deaminase (AID) diversifies immunoglobulin through somatic hypermutation (SHM) and class-switch recombination (CSR). AID-transgenic mice develop T-lymphoma, indicating that constitutive expression of AID leads to tumorigenesis. Here, we transplanted mouse bone marrow cells transduced with AID. Twenty-four of the 32 recipient mice developed T-lymphoma 2–4 months after the transplantation. Surprisingly, unlike AID-transgenic mice, seven recipients developed B-leukemia/lymphoma with longer latencies. None of the mice suffered from myeloid leukemia. When we used nude mice as recipients, they developed only B-leukemia/lymphoma, presumably due to lack of thymus. Analysis of AID mutants suggested that an intact form with SHM activity is required for maximum ability of AID to induce lymphoma. Except for a K-ras active mutant in one case, specific mutations could not be identified in T-lymphoma; however, Notch1 was constitutively activated in most cases. Importantly, truncations of Ebf1 or Pax5 were observed in B-leukemia/lymphoma. In conclusion, this is the first report on the potential of AID overexpression to promote B-cell lymphomagenesis in a mouse model. Aberrant expression of AID in bone marrow cells induced leukemia/lymphoma in a cell-lineage–dependent manner, mainly through its function as a mutator.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999; 274: 18470–18476.

    Article  CAS  PubMed  Google Scholar 

  2. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T . Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102: 553–563.

    Article  CAS  PubMed  Google Scholar 

  3. Ta VT, Nagaoka H, Catalan N, Durandy A, Fischer A, Imai K et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat Immunol 2003; 4: 843–848.

    Article  CAS  PubMed  Google Scholar 

  4. Shinkura R, Ito S, Begum NA, Nagaoka H, Muramatsu M, Kinoshita K et al. Separate domains of AID are required for somatic hypermutation and class-switch recombination. Nat Immunol 2004; 5: 707–712.

    Article  CAS  PubMed  Google Scholar 

  5. Barreto V, Reina-San-Martin B, Ramiro AR, McBride KM, Nussenzweig MC . C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol Cell 2003; 12: 501–508.

    Article  CAS  PubMed  Google Scholar 

  6. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412: 341–346.

    Article  CAS  PubMed  Google Scholar 

  7. Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, Castle BE et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 2003; 101: 3574–3580.

    Article  CAS  PubMed  Google Scholar 

  8. Smit LA, Bende RJ, Aten J, Guikema JE, Aarts WM, van Noesel CJ . Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res 2003; 63: 3894–3898.

    CAS  PubMed  Google Scholar 

  9. Klemm L, Duy C, Iacobucci I, Kuchen S, von Levetzow G, Feldhahn N et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell 2009; 16: 232–245.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Pasqualucci L, Bhagat G, Jankovic M, Compagno M, Smith P, Muramatsu M et al. AID is required for germinal center-derived lymphomagenesis. Nat Genet 2008; 40: 108–112.

    Article  CAS  PubMed  Google Scholar 

  11. Takizawa M, Tolarova H, Li Z, Dubois W, Lim S, Callen E et al. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J Exp Med 2008; 205: 1949–1957.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 2007; 13: 470–476.

    Article  CAS  PubMed  Google Scholar 

  13. Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med 2003; 197: 1173–1181.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Morisawa T, Marusawa H, Ueda Y, Iwai A, Okazaki IM, Honjo T et al. Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression. Int J Cancer 2008; 123: 2735–2740.

    Article  CAS  PubMed  Google Scholar 

  15. Rucci F, Cattaneo L, Marrella V, Sacco MG, Sobacchi C, Lucchini F et al. Tissue-specific sensitivity to AID expression in transgenic mouse models. Gene 2006; 377: 150–158.

    Article  CAS  PubMed  Google Scholar 

  16. Muto T, Okazaki IM, Yamada S, Tanaka Y, Kinoshita K, Muramatsu M et al. Negative regulation of activation-induced cytidine deaminase in B cells. Proc Natl Acad Sci USA 2006; 103: 2752–2757.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Casellas R, Yamane A, Kovalchuk AL, Potter M . Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes. Immunology 2009; 126: 316–328.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Morita S, Kojima T, Kitamura T . Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000; 7: 1063–1066.

    Article  CAS  PubMed  Google Scholar 

  19. Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 2003; 31: 1007–1014.

    Article  CAS  PubMed  Google Scholar 

  20. Watanabe-Okochi N, Kitaura J, Ono R, Harada H, Harada Y, Komeno Y et al. AML1 mutations induced MDS and MDS/AML in a mouse BMT model. Blood 2008; 111: 4297–4308.

    Article  CAS  PubMed  Google Scholar 

  21. Ye BH, Chaganti S, Chang CC, Niu H, Corradini P, Chaganti RS et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J 1995; 14: 6209–6217.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Pasqualucci L, Migliazza A, Basso K, Houldsworth J, Chaganti RS, Dalla-Favera R . Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 2003; 101: 2914–2923.

    Article  CAS  PubMed  Google Scholar 

  23. Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008; 453: 110–114.

    Article  CAS  PubMed  Google Scholar 

  24. Longerich S, Tanaka A, Bozek G, Nicolae D, Storb U . The very 5′ end and the constant region of Ig genes are spared from somatic mutation because AID does not access these regions. J Exp Med 2005; 202: 1443–1454.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Aster JC, Pear WS, Blacklow SC . Notch signaling in leukemia. Annu Rev Pathol 2008; 3: 587–613.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446: 758–764.

    Article  CAS  PubMed  Google Scholar 

  27. Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, Muramatsu M et al. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 2004; 118: 431–438.

    Article  CAS  PubMed  Google Scholar 

  28. Muto T, Okazaki IM, Yamada S, Tanaka Y, Kinoshita K, Muramatsu M et al. Negative regulation of activation-induced cytidine deaminase in B cells. Proc Natl Acad Sci USA 2006; 103: 2752–2757.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Liu M, Schatz DG . Balancing AID and DNA repair during somatic hypermutation. Trends Immunol 2009; 30: 173–181.

    Article  PubMed  Google Scholar 

  30. Geisberger R, Rada C, Neuberger MS . The stability of AID and its function in class-switching are critically sensitive to the identity of its nuclear-export sequence. Proc Natl Acad Sci USA 2009; 106: 6736–6741.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. O’Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 2007; 204: 1813–1824.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Dr Chiba (Tsukuba University, Ibaraki, Japan) for providing HPB-ALL cell line. We are grateful to Dr Dovie Wylie for her excellent language assistance. This work was supported by grants from the Ministry of Education, Science, Technology, Sports and Culture, Japan to TK.

Author information

Authors and Affiliations

  1. Division of Cellular Therapy, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo, Japan

    Y Komeno, J Kitaura, N Kato, T Oki, F Nakahara & T Kitamura

  2. Division of Stem Cell Signaling, Center for Stem Cell Therapy, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo, Japan

    Y Komeno, J Kitaura, N Kato, T Oki, F Nakahara & T Kitamura

  3. Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan

    N Watanabe-Okochi

  4. Department of Transfusion Medicine, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan

    N Watanabe-Okochi

  5. International Radiation Information Center, Research Institute for Radiation Biology and Medicine, Hiroshima University, Minami-ku, Hiroshima, Japan

    Y Harada

  6. Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Minami-ku, Hiroshima, Japan

    H Harada

  7. Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan

    R Shinkura, H Nagaoka & T Honjo

  8. Department of Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Gunma, Japan

    Y Hayashi

Authors
  1. Y Komeno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Kitaura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N Watanabe-Okochi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Oki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F Nakahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y Harada
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H Harada
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R Shinkura
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H Nagaoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Y Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. T Honjo
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. T Kitamura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T Kitamura.

Ethics declarations

Competing interests

TK serves as a consultant for R&D Systems.

Additional information

Supplementary Information accompanies the paper on the Leukemia website ()

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Komeno, Y., Kitaura, J., Watanabe-Okochi, N. et al. AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model. Leukemia 24, 1018–1024 (2010). https://doi.org/10.1038/leu.2010.40

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2010.40

Keywords

This article is cited by

Search

Advanced search

Quick links